VeriSign, Inc.
VRSN - NASDAQ - $288.21 ▲ +%3.50
-
Earnings Thu 23 Jul

VeriSign opens the
books on Thursday evening.

1 analysts' median target is $355[FMP target], stock is $288, +23.2% upside potential. After Q1 +1.7% EPS beat[FMP earnings], the stock moved -2.8%.

summary below
Quick Take - in 40 seconds
B-
BUY Council 2/6 - Moonshot 64

B- = MoonshotScore 64[9-pillar formula] + Council 2/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $433.0M[FMP est], EPS $2.37[FMP est]. 1 consecutive quarters of beat[FMP earnings].

$2.37 EPS Estimate Last year $2.23 - +7% YoY YoY
1 Beat Streak Expectations beaten consecutively for the last 1 quarters

Q1 EPS +1.7% beat[FMP] but the stock -2.8% D+1[FMP D+1]. John Calys promised $7.2M CapEx + a sequential decline in Q4 during the Q1 earnings call[John Calys capex transcript].

Watchlist

5 metrics stand out this quarter.

3.1% Expectation / Guide

Domain Name Base Growth Guidance

domain_name_base_growth_guidance

VeriSign is increasing and narrowing its guidance for domain name base growth to be between 3.1% and 4.3% for 2026.

"With the trends we've observed thus far in 2026 and our expectations for the next 3 quarters, we are increasing and narrowing our guidance for domain name base growth to be between 3.1% and 4.3% for 2026."

- Jim Bidzos, Executive Chairman, President and CEO - Q1 FY26 Earnings Call - April 23, 2026
100% Investor Focus

Free Cash Flow Return

free_cash_flow_return

After seeing to the needs of our operations, we returned over 100% of our free cash flow to the investing public in the last 12 months for a total of $1.13 billion through share repurchases and dividends.

"After seeing to the needs of our operations, we returned over 100% of our free cash flow to the investing public in the last 12 months for a total of $1.13 billion through share repurchases and dividends."

- Jim Bidzos, Executive Chairman, President and CEO - Q1 FY26 Earnings Call - April 23, 2026
$0.71 Investor Focus

Com Price Increase

com_price_increase

VeriSign has given notice of a price increase of $0.71 to the annual wholesale price for .com domain names, which raises the wholesale price from $10.26 to $10.97 effective November 1, 2026.

"As announced in today's earnings release, we have given notice of a price increase of $0.71 to the annual wholesale price for .com domain names, which raises the wholesale price from $10.26 to $10.97 effective November 1, 2026."

- Jim Bidzos, Executive Chairman, President and CEO - Q1 FY26 Earnings Call - April 23, 2026
$0.81 Investor Focus

Quarterly Dividend

quarterly_dividend

VeriSign's Board of Directors approved a cash dividend of $0.81 per share of VeriSign's outstanding common stock to stockholders of record as of the close of business on May 19, 2026, payable on May 27, 2026.

"As announced in today's earnings release, VeriSign's Board of Directors approved a cash dividend of $0.81 per share of VeriSign's outstanding common stock to stockholders of record as of the close of business on May 19, 2026, payable on May 27, 2026."

- Jim Bidzos, Executive Chairman, President and CEO - Q1 FY26 Earnings Call - April 23, 2026
$863 million Investor Focus

Share Repurchase Program

share_repurchase_program

Also at quarter end, there was $863 million remaining available under our current share repurchase program, which has no expiration.

"Also at quarter end, there was $863 million remaining available under our current share repurchase program, which has no expiration."

- Jim Bidzos, Executive Chairman, President and CEO - Q1 FY26 Earnings Call - April 23, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 2 / 6 Bullish

6 investor frameworks. 2 bullish (Ray Dalio, Ken Griffin), 0 bearish (none), 4 neutral (Jim Simons, Klarman, Buffett, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +23.2%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 70
Klarman value - target upside +23.2%
Buffett quality - ROE score 1/5
Munger valuation - target upside +23.2%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCTight
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
69.8 RSI 69.8 positive momentum, 50d above
MACD
+12.00 price above 50d - support positive
50d MA
$257 stock 12.0% above - short-term support
200d MA
$256 stock 12.5% above - long-term support
Volume (10d)
+20% increase - pre-earnings positioning
Resistance
$355
Analyst median target - upgrade trigger if broken
Current
$288
Pre-earnings position
Support
$218
Invalidation - close below this is a technical breakdown
Pattern
Range
$218-$355 band - earnings breakout/breakdown trigger

Past Performance

VeriSign,'s last 8 quarters: 1 consecutive beats.

BEAT
Q2 FY25
$2.21 vs $2.20 est - +6.7%
BEAT
Q3 FY25
$2.27 vs $2.25 est - -1.4%
MISS
Q4 FY25
$2.23 vs $2.35 est - -7.6%
BEAT
Q1 FY26
$2.34 vs $2.30 est - -2.8%

Q1 (April 23, 2026): EPS $2.34 vs $2.30 est[FMP], +1.7% beat. D+1 movement: -2.8%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $2.30 (no guidance)

Q1: EPS $2.34 vs $2.30 beat[FMP], stock -2.8% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $7.2M[FMP cashflow]. Q1 op margin 68.5%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $2.37 + CapEx discipline
Threshold: EPS > $2.37[FMP est].
Target: Break above median target $355[FMP][FMP target]; high target $355 upper bound.
Scenario B - In-Line
EPS approx $2.37 + CapEx < $7.2M
Threshold: EPS approx $2.37[FMP est], Q4 CapEx < $7.2M[FMP].
Target: Consolidation in the band between current $288[FMP] and median $355[FMP].
Scenario C - Miss
EPS < $2.30 or CapEx >= $7.2M
Threshold: EPS < $2.30[FMP estx0.97].
Target: Current $288 below SMA200 $256[FMP], if rejection continues, $218[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 1 analysts say?

Wall Street Consensus
$355
12-month median target price (+23.2% upside potential)
2
BUY
2
HOLD
0
SELL
Risk Management
$218
Invalidation level - critical support threshold
$257 - 50-day MA (above, +12.0%)
$256 - 200-day MA (above, +12.5%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - VRSN Q4 FY26
B-

You read it in 5 minutes. When the numbers come out on Thursday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Thursday evening. The framework is ready on this page: Q4 EPS threshold $2.37[FMP], CapEx threshold "below $7.2M"[John Calys]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jul 23, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
Jul 24, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 6, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Oct 23, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the VRSN earnings preview cover?

This VRSN (VRSN) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in VRSN earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.